{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:33:03Z","timestamp":1793291583896,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jaci.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:12:37Z","timestamp":1649142757000},"page":"1137-1149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Angelo Valerio","family":"Marzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Maronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Asero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-0763","authenticated-orcid":false,"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.02.007_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2500\/aap.2007.28.2972","article-title":"Urticarial vasculitis","volume":"28","author":"Chang","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/CRIAI:23:2:201","article-title":"Urticarial vasculitis","volume":"23","author":"Venzor","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2230.1996.tb00146.x","article-title":"Consensus meeting on the definition of physical urticarias and urticarial vasculitis","volume":"21","author":"Black","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2022.02.007_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Sunderk\u00f6tter","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2022.02.007_bib6","first-page":"340","article-title":"Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome","volume":"48","author":"McDuffie","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJM197706232962505","article-title":"Chronic urticaria as a manifestation of necrotizing venulitis","volume":"296","author":"Soter","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0002-9343(80)90216-8","article-title":"A hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease","volume":"68","author":"Zeiss","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib9","first-page":"231","article-title":"Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease","volume":"57","author":"Schwartz","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0190-9622(82)70139-2","article-title":"The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases","volume":"7","author":"Sanchez","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00005792-199501000-00003","article-title":"Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients","volume":"74","author":"Wisnieski","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(24)00193-2","article-title":"Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis","volume":"38","author":"Davis","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2007.02641.x","article-title":"Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India","volume":"22","author":"Dincy","year":"2008","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.jaci.2022.02.007_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2022.02.007_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2230.2008.02891.x","article-title":"A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients","volume":"34","author":"Tosoni","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ad.2012.12.004","article-title":"Urticarial vasculitis: a retrospective study of 15 cases","volume":"104","author":"Moreno-Su\u00e1rez","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaci.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.1982.tb00295.x","article-title":"Urticarial vasculitis: a report of nine cases and review of the literature","volume":"107","author":"Callen","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MD.0000000000000013","article-title":"Urticarial vasculitis in northern Spain: clinical study of 21 cases","volume":"93","author":"Loricera","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2022.02.007_bib20","first-page":"513","article-title":"Clinical characteristics and treatment outcomes in patients with urticarial vasculitis","volume":"8","author":"Serarslan","year":"2020","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.jaci.2022.02.007_bib21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaad.2006.10.962","article-title":"Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis","volume":"56","author":"Lee","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib22","article-title":"Clinicopathological profile and outcome of childhood urticaria vasculitis: an observational study","volume":"12","author":"Satapathy","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2022.02.007_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/JAA.S304099","article-title":"Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis","volume":"14","author":"Liu","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2022.02.007_bib24","first-page":"286","article-title":"Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: a report of three cases and literature review","volume":"38","author":"Rattananukrom","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5021\/ad.2019.31.3.335","article-title":"Omalizumab as a succesfull therapy in normocomplementemic urticarial vasculitis: a series of four patients and review of the literature","volume":"31","author":"Degirmentepe","year":"2019","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijwd.2021.01.021","article-title":"Urticarial vasculitis","volume":"7","author":"Gu","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib27","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.mayocp.2014.04.015","article-title":"Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota","volume":"89","author":"Arora","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/rheumatology\/key110","article-title":"Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)","volume":"57","author":"Sj\u00f6wall","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2022.02.007_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archderm.1984.01650400066014","article-title":"Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice","volume":"120","author":"Eaf","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/DAD.0000000000001170","article-title":"Role of direct immunofluorescence in cutaneous small-vessel vasculitis: experience from a tertiary center","volume":"40","author":"Lath","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaci.2022.02.007_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.13952","article-title":"Leukocytoclastic vasculitis in children: clinical characteristics, subtypes, causes and direct immunofluorescence findings of 56 biopsy-confirmed cases","volume":"31","author":"Johnson","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib32","first-page":"191","article-title":"Urticarial vasculitis","volume":"18","author":"Cardoso","year":"1990","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaci.2022.02.007_bib33","first-page":"166","article-title":"Urticarial vasculitis","volume":"14","author":"O\u2019Donnell","year":"1995","journal-title":"Int Angiol"},{"key":"10.1016\/j.jaci.2022.02.007_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000372-198912000-00003","article-title":"Incidence of leukocytoclastic vasculitis in chronic idiopathic urticaria. Study of 100 cases","volume":"11","author":"Peteiro","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaci.2022.02.007_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdcr.2021.02.019","article-title":"Unusual purpuric eruption in a child","volume":"11","author":"Lin","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2022.02.007_bib36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jaad.2020.12.031","article-title":"Clinical spectrum of childhood-onset hypocomplementemic urticarial vasculitis in Oman: a retrospective multicenter study","volume":"85","author":"Al Musalhi","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmii.2011.09.024","article-title":"Kawasaki disease and Henoch-Sch\u00f6nlein purpura \u201410 years\u2019 experience of childhood vasculitis at a university hospital in Taiwan","volume":"45","author":"Teng","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jaci.2022.02.007_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archderm.134.1.88","article-title":"Pathophysiology of urticarial vasculitis","volume":"134","author":"Mehregan","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI200422820","article-title":"Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus","volume":"114","author":"Holers","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.02.007_bib41","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4049\/jimmunol.148.5.1396","article-title":"Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus","volume":"148","author":"Wisnieski","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib42","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3389\/fimmu.2019.02619","article-title":"Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr virus-derived antigenic site","volume":"10","author":"Csorba","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/jmv.20893","article-title":"EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome","volume":"79","author":"Berggren","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2022.02.007_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-3083.1996.d01-48.x","article-title":"Human autoantibodies against Clq: lack of cross reactivity with the collectins mannan-binding protein, lung surfactant protein A\u00a0and bovine conglutinin","volume":"43","author":"M\u00e5rtensson","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib45","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.jaip.2020.05.031","article-title":"Chronic obstructive pulmonary disease associated with hypocomplementemic urticarial vasculitis","volume":"8","author":"David","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.02.007_bib46","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.3390\/jcm9072131","article-title":"Kidney involvement in hypocomplementemic urticarial vasculitis syndrome\u2014a case-based review","volume":"9","author":"Ion","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib47","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10067-019-04548-8","article-title":"Exceptional association of hypocomplementemic urticarial vasculitis syndrome (HUVS) and symptomatic pulmonary histoplasmosis: a case-based literature review","volume":"38","author":"Alomari","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib48","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1111\/jdv.16713","article-title":"Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?","volume":"34","author":"de Perosanz-Lobo","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib49","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMe0811014","article-title":"Interleukin-1beta and the autoinflammatory diseases","volume":"360","author":"Dinarello","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.04.008","article-title":"Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study","volume":"132","author":"Krause","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib51","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.38010","article-title":"DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome","volume":"65","author":"Oz\u00e7akar","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2022.02.007_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil extracellular traps (NETs) profiles in patients with incident SLE and lupus nephritis","volume":"47","author":"Bruschi","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","article-title":"Skin and systemic inflammation in Schnitzler\u2019s syndrome are associated with neutrophil extracellular trap formation","volume":"10","author":"Bonnekoh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib54","first-page":"41","article-title":"Urticarial vasculitis and urticarial autoinflammatory syndromes","volume":"150","author":"Marzano","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100107","article-title":"Management of urticarial vasculitis: a worldwide physician perspective","volume":"13","author":"Kolkhir","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2022.02.007_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.iac.2013.09.007","article-title":"Urticarial vasculitis and Schnitzler syndrome","volume":"34","author":"Zuberbier","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2022.02.007_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000045981","article-title":"Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy","volume":"88","author":"Saeki","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.jaci.2022.02.007_bib58","first-page":"409","article-title":"Crescentic glomerulonephritis complicating the course of a hypocomplementemic urticarial vasculitis","volume":"54","author":"Messiaen","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaci.2022.02.007_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nephro.2019.09.004","article-title":"N\u00e9phropathie associ\u00e9e \u00e0 une vascularite urticarienne hypocompl\u00e9ment\u00e9mique: pr\u00e9sentation d\u2019un cas clinique et revue de la litt\u00e9rature [Nephropathy associated with hypocomplementemic urticarial vasculitis: a case report and literature review]","volume":"16","author":"Boyer","year":"2020","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.jaci.2022.02.007_bib60","first-page":"36","article-title":"Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review","volume":"5","author":"Buck","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib61","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11926-009-0060-y","article-title":"Hypocomplementemic urticarial vasculitis syndrome","volume":"11","author":"Jara","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaci.2022.02.007_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.11604\/pamj.2016.24.285.8168","article-title":"Atteinte pulmonaire s\u00e9v\u00e8re au cours de la vascularite hypocompl\u00e9ment\u00e9mique urticarienne [Severe pulmonary involvement in hypocomplementemic urticarial vasculitis (HUV)]","volume":"24","author":"Raoufi","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jaci.2022.02.007_bib63","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1378\/chest.14-1193","article-title":"A 41-year-old woman with shortness of breath and history of rash and recurrent laryngeal edema","volume":"147","author":"Ataya","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2022.02.007_bib64","article-title":"Urticarial vasculitis-associated intestinal ischemia","volume":"2016","author":"Wong","year":"2016","journal-title":"Case Rep Gastrointest Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib65","first-page":"3","article-title":"Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions","volume":"11","author":"Jayakanthan","year":"2017","journal-title":"Int J Health Sci (Qassim)"},{"key":"10.1016\/j.jaci.2022.02.007_bib66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2008.06.006","article-title":"Anti-C1q autoantibodies","volume":"7","author":"Kallenberg","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2022.02.007_bib67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ijd.14387","article-title":"Eosinophilic infiltration: an under-reported histological finding in urticarial vasculitis","volume":"58","author":"Kamyab","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/DAD.0000000000001501","article-title":"Dermal C4d deposition and neutrophil alignment along the dermal-epidermal junction as a diagnostic adjunct for hypocomplementemic urticarial vasculitis (anti-C1q vasculitis) and underlying systemic disease","volume":"42","author":"Damman","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaci.2022.02.007_bib69","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fimmu.2019.00627","article-title":"Autoimmune theories of chronic spontaneous urticaria","volume":"10","author":"Bracken","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129456","article-title":"Activation of blood coagulation in two prototypic autoimmune skin diseases: a possible link with thrombotic risk","volume":"10","author":"Cugno","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.02.007_bib73","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1038\/s41598-020-63146-w","article-title":"Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis","volume":"10","author":"Garc\u00eda-Garc\u00eda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2022.02.007_bib74","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jaip.2021.03.033","article-title":"The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells","volume":"9","author":"Gim\u00e9nez-Arnau","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.02.007_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12031","article-title":"A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria","volume":"11","author":"Puhl","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2022.02.007_bib76","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.02.007_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaad.2020.04.060","article-title":"Clinical and immunopathologic features of idiopathic cutaneous immunoglobulin M\/G vasculitis versus idiopathic skin-limited immunoglobulin A\u00a0vasculitis","volume":"84","author":"Marzano","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2008.12.010","article-title":"The 100th anniversary of lupus erythematosus tumidus","volume":"8","author":"Kuhn","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2022.02.007_bib79","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/CCID.S166723","article-title":"Lupus erythematosus tumidus: clinical perspectives","volume":"12","author":"Patsinakidis","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib80","article-title":"Tumid lupus erythematosus: a rare and distinctive variant of cutaneous lupus erythematosus masquerading as urticarial vasculitis","volume":"12","author":"Liu","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2022.02.007_bib81","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archderm.142.9.1157","article-title":"Wells syndrome in adults and children: a report of 19 cases","volume":"142","author":"Caputo","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib82","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40257-020-00520-4","article-title":"Eosinophilic dermatoses: recognition and management","volume":"21","author":"Marzano","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib83","series-title":"StatPearls","article-title":"Wells syndrome. 2021","author":"Toumi","year":"2021"},{"key":"10.1016\/j.jaci.2022.02.007_bib84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2340\/0001555566213219","article-title":"The histopathogenesis of the flame figure in Wells\u2019 syndrome based on five cases","volume":"66","author":"Brehmer-Andersson","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib85","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib86","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1523-1747.ep12543806","article-title":"Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes","volume":"74","author":"Bushkell","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12016-017-8667-7","article-title":"Current perspectives on erythema multiforme","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib88","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.13443","article-title":"Cutaneous mastocytosis: a dermatological perspective","volume":"62","author":"Di Raimondo","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib89","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2013.5480","article-title":"Neutrophilic urticaria with systemic inflammation identical to neutrophilic urticarial dermatosis","volume":"149","author":"Lipsker","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib90","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.annder.2018.06.010","article-title":"Neutrophilic urticarial dermatosis: a review","volume":"145","author":"Gusdorf","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib91","doi-asserted-by":"crossref","unstructured":"Gellrich FF, G\u00fcnther C. Schnitzler syndrome [published online ahead of print June 5, 2019]. Hautarzt. https:\/\/doi.org\/10.1007\/s00105-019-4434-4.","DOI":"10.1007\/s00105-019-4434-4"},{"key":"10.1016\/j.jaci.2022.02.007_bib92","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2022.02.007_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib94","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2022.02.007_bib95","first-page":"32","article-title":"A dermatologic perspective on autoinflammatory diseases","volume":"36","author":"Marzano","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib97","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib98","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaad.2021.01.023","article-title":"Italian Skin COVID-19 Network of the Italian Society of Dermatology and Sexually Transmitted Diseases. The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicenter study of 200 adult patients","volume":"84","author":"Marzano","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib99","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2009.11.686","article-title":"Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria, part I: cutaneous diseases","volume":"62","author":"Peroni","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/idoj.IDOJ_127_21","article-title":"An observational study of mucocutaneous manifestations among SARS-CoV-2 patients from three COVID-19 dedicated tertiary care centers","volume":"12","author":"Mohta","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaci.2022.02.007_bib101","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1111\/jdv.17391","article-title":"Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?","volume":"35","author":"Criado","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib102","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ijd.15112","article-title":"Urticarial vasculitis in a COVID-19 recovered patient","volume":"59","author":"Nasiri","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clindermatol.2020.12.004","article-title":"Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns","volume":"39","author":"Rongioletti","year":"2021","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib104","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/jdv.17381","article-title":"Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection","volume":"35","author":"Barrera-God\u00ednez","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/dermatopathology7010002","article-title":"Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature","volume":"7","author":"Kaya","year":"2020","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.jaci.2022.02.007_bib106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study","volume":"86","author":"McMahon","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib107","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/vaccines9091011","article-title":"Increased risk of urticaria\/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors","volume":"9","author":"Cugno","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jaci.2022.02.007_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib109","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catal\u00e0","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.02.007_bib110","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/all.14839","article-title":"Skin tests in urticaria\/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: limits of intradermal testing","volume":"76","author":"Bianchi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.02.007_bib111","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.02.007_bib112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2500\/aap.2022.43.210111","article-title":"Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2","volume":"43","author":"Magen","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib113","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15093","article-title":"COVID-19 vaccine-induced urticarial vasculitis","volume":"34","author":"Dash","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2022.02.007_bib114","article-title":"Urticarial vasculitis following mRNA anti-COVID-19 vaccine","author":"Nazzaro","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2022.02.007_bib115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/CRIAI:30:1:025","article-title":"Urticaria and hepatitis","volume":"30","author":"Cribier","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1710-1492-5-10","article-title":"Urticaria and infections","volume":"5","author":"Wedi","year":"2009","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.007_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2500\/aap.2016.37.3915","article-title":"Association between urticaria and virus infections: a systematic review","volume":"37","author":"Imbalzano","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2022.02.007_bib118","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jfma.2018.01.022","article-title":"Acute respiratory distress syndrome in a man with Epstein-Barr virus infection-induced hypocomplementemic urticarial vasculitis","volume":"117","author":"Tsai","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jaci.2022.02.007_bib119","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(98)70089-1","article-title":"Urticarial vasculitis caused by hepatitis C virus infection: response to interferon alfa therapy","volume":"39","author":"Hamid","year":"1998","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:35:15Z","timestamp":1758792915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0091674922002251"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.02.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}